Medifast, Inc. (MED) Q1 2026 Earnings Call Transcript
Medifast, Inc. (MED) Q1 2026 Earnings Call Transcript
Kaplan International student enrollment volumes, particularly from China and Middle East markets where visa policies and currency fluctuations drive demand
Political advertising revenue in even-numbered years (2026 midterm cycle currently underway), which can add $30-50M incremental revenue to TV segment
Capital allocation announcements including share buybacks (company has repurchased ~15% of shares over past 5 years) and acquisition activity
Foreign exchange headwinds/tailwinds given 40%+ international revenue exposure, particularly GBP and AUD movements
moderate - Education revenue shows counter-cyclical characteristics (enrollment rises during weak job markets as workers seek retraining) but international student flows are pro-cyclical (dependent on emerging market wealth). TV advertising is moderately cyclical, declining 10-15% in recessions. Manufacturing/automotive segments are highly cyclical. Net effect is moderate sensitivity with education providing partial hedge.
Rising rates have modest negative impact through higher financing costs for acquisitions and working capital, though minimal given low 0.26x debt/equity ratio. Higher rates reduce valuation multiples for conglomerate structures. Positive impact on $1.2B+ cash balance earning higher yields. Student loan availability at higher rates may marginally reduce education demand, though most Kaplan programs are shorter-duration professional training less dependent on federal loans.
Secular decline in traditional test preparation (SAT/ACT) as universities adopt test-optional policies, reducing Kaplan's legacy revenue base
Shift to online education and free alternatives (Khan Academy, Coursera) pressuring pricing power for standardized test prep and professional training
Cord-cutting and streaming migration reducing linear TV viewership and advertising effectiveness, threatening broadcast station valuations
value - Attracts deep value investors seeking conglomerate discount opportunities, family-controlled stability (Graham family retains voting control), and disciplined capital allocation. The 1.0x P/B and 4.0x EV/EBITDA multiples appeal to investors willing to look through operational complexity for asset value. Strong FCF generation (6.9% yield) and buyback history attract value-oriented funds. Low institutional ownership (~60%) reflects complexity and small float.
No analyst coverage available for this stock.
1 signal unavailable — limited data for this stock
Trend
+2.8% vs SMA 50 · +3.6% vs SMA 200
Momentum
Volume distribution is neutral or leaning toward distribution. No compelling squeeze setup based on current money flow data.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2023 | $4.4B $4.4B–$4.4B | — | $43.00 | — | — | Low1 |
FY2024 | $4.8B $4.8B–$4.8B | ▲ +9.0% | $62.50 | ▲ +45.3% | — | Low1 |
FY2025 | $5.0B $5.0B–$5.0B | ▲ +3.1% | $51.29 | ▼ -17.9% | — | Low1 |
Dividend per payment — last 8 periods
Medifast, Inc. (MED) Q1 2026 Earnings Call Transcript
graham holdings company (nyse: ghc) is a diversified education and media company whose principal operations include educational services, television broadcasting, cable systems and online, print and local tv news. the company owns kaplan, a leading global provider of educational services; graham media group (wdiv–detroit, kprc–houston, wkmg–orlando, ksat–san antonio, wjxt–jacksonville); cable one, serving small-city subscribers in 19 midwestern, western and southern states; the slate group (slate, slate v, theroot); and foreign policy. the company also owns trove, a digital team focused on innovation and experimentation with emerging technologies; socialcode, a leading social marketing solutions company; celtic healthcare; forney corporation; joyce/dayton corp.; and residential healthcare group.
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
GHC◀ | $1119.88 | +1.06% | $4.9B | 16.5 | +251.9% | 595.1% | 1500 |
| $272.05 | +1.27% | $2.9T | 31.8 | +1237.8% | 1083.4% | 1515 | |
| $392.51 | +2.41% | $1.5T | 326.1 | -293.1% | 400.1% | 1490 | |
| $312.42 | -1.50% | $322.6B | 22.7 | +324.0% | 859.6% | 1485 | |
| $284.10 | -2.37% | $203.8B | 23.9 | +372.3% | 3185.0% | 1488 | |
| $154.64 | +0.05% | $174.2B | 32.1 | +711.9% | 910.0% | 1510 | |
| $165.58 | +0.75% | $131.4B | 21.8 | +1338.7% | 2007.7% | 1489 | |
| Sector avg | — | +0.24% | — | 67.8 | +563.4% | 1291.6% | 1497 |